First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia Our study demonstrated that ...
Gift 5 articles to anyone you choose each month when you subscribe. Listed mortgage company RHG, formally RAMS Mortgage Corp, has engaged with suitor Resimac and opened the door to a period of due ...
On Monday, RHG directors announced they had agreed to accept the latest bid of 48 cents per share as well as a three-cent-per share dividend, with total payments of 51 cents per share. The total puts ...
TWO days after the RHG board recommended a takeover deal to investors, the company has received a rival bid for the mortgage business. Pepper has put an offer to the RHG board which would see ...
Pepper, which typically provides low-doc loans, yesterday unveiled an offer of 46c a share for RHG, which it claimed was "superior" to a bid by rival non-bank Resimac and dealmaker Trevor Loewensohn.
Add articles to your saved list and come back to them any time. The RHG saga continues unabated, with stock in the re-named Rams Home Loan book climbing 20 per cent since hitting a low of 40 cents on ...
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia We conducted a phase II, ...
Mortgage business RHG, formerly RAMS Home loans, has accepted a sweetened takeover bid by lender Resimac, trumping a rival bid. On Monday, RHG directors announced they had agreed to accept the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results